Manufacturer
Sanofi S.p.A.
Contents
Ramipril
Indication
Hypertension, Heart failure, Post-myocardial infarction, Prophylaxis of cardiovascular events in high-risk patients.
Instruction
May be taken with or without food.
Drug interaction
May enhance hypotensive effect w/ diuretics and other antihypertensives. May increase risk of renal function deterioration w/ NSAIDs. May increase serum levels and toxicity of lithum. May increase hyperkalaemic effect w/ K-sparing diuretics and supplements. Potentially Fatal: Concomitant use w/ aliskiren may increase the risk of hyperkalaemia, hypotension and nephrotoxicity in patients w/ diabetes or renal impairment.
Malaysia
